Related references
Note: Only part of the references are listed.Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure
Eric J. Velazquez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
John J. V. McMurray et al.
HEART (2018)
Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction
Ki Hong Choi et al.
HEART (2018)
Mortality and Readmission Following Hospitalisation for Heart Failure in Australia: A Systematic Review and Meta-Analysis
Mohammed S. Al-Omary et al.
HEART LUNG AND CIRCULATION (2018)
Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction
Gianluigi Savarese et al.
JOURNAL OF CARDIAC FAILURE (2018)
When more is less and less is more: Is there an additional value of NT-proBNP in risk stratification in heart failure?
Petar M. Seferovic et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2018)
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018
John J. Atherton et al.
HEART LUNG AND CIRCULATION (2018)
A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
G. C. M. Linssen et al.
NETHERLANDS HEART JOURNAL (2018)
IMPROV-ED study: outcomes after discharge for an episode of acute-decompensated heart failure and comparison between patients discharged from the emergency department and hospital wards
Oscar Miro et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure
Edward A. Griffin et al.
VALUE IN HEALTH (2017)
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure A Scientific Statement From the American Heart Association
Sheryl L. Chow et al.
CIRCULATION (2017)
Economic evaluation of medicines
Colman Taylor et al.
AUSTRALIAN PRESCRIBER (2017)
COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN (FORMERLY LCZ696) IN CHRONIC HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION - AN ANALYSIS FOR SWITZERLAND
Z. Ademi et al.
VALUE IN HEALTH (2016)
Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study
Pardeep S. Jhund et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
Milton Packer et al.
CIRCULATION (2015)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
Uwe Siebert et al.
VALUE IN HEALTH (2012)
Development of an economic model to assess the cost-effectiveness of hawthorn extract as an adjunct treatment for heart failure in Australia
Emily Ford et al.
BMJ OPEN (2012)
Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes Data From Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Linked to Medicare Claims
Robb D. Kociol et al.
CIRCULATION-HEART FAILURE (2011)
Diagnostic and Prognostic Significance of Plasma N-Terminal-Pro-Brain Natriuretic Peptide in Decompensated Heart Failure with Preserved Ejection Fraction
Biju Paul et al.
HEART LUNG AND CIRCULATION (2008)
Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization
Paulo Bettencourt et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Overview of acute decompensated heart failure in Argentina: Lessons learned from 5 registries during the last decade
ER Perna et al.
AMERICAN HEART JOURNAL (2006)
N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients
P Bettencourt et al.
CIRCULATION (2004)
Share Paper
